Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HAL PDT in Low-grade CIN1
NCT00708942Phase 2Terminated
- Sponsor
- Photocure
- Start
- Jan 2009
- Primary completion
- Jan 2012
- Modality
- Small Molecules
- Countries
- 3
01
Overview
Phase 2, randomised, open-label trial of hexaminolevulinate in cervical intraepithelial neoplasia (CIN) (5 arms), sponsored by Photocure. Primary endpoint: Complete Response Rate at 6 months. Started Jan 2009; status: terminated.
02
Drugs
hexaminolevulinate
03
Conditions
cervical intraepithelial neoplasia (CIN)
Beyond the preview
Go deeper on NCT00708942.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00708942.